amikacin has been researched along with Communicable Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Agoons, BB; Etoga, MCE; Jingi, AM; Mbanya, JC; Mekobe, FM; Ngassam, E; Sobngwi, E; Yefou, MD | 1 |
| Beekmann, SE; Graham, DR; Gundlapalli, AV; Polgreen, PM | 1 |
| Bertrand, A; Lepeu, G | 1 |
3 other study(ies) available for amikacin and Communicable Diseases
| Article | Year |
|---|---|
Bacterial profile of diabetic foot infections and antibiotic susceptibility in a specialized diabetes centre in Cameroon.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cameroon; Communicable Diseases; Diabetes Mellitus, Type 2; Diabetic Foot; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2022 |
Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists.
Topics: Amikacin; Anti-Infective Agents; Aztreonam; Communicable Diseases; Delivery of Health Care; Drug Substitution; Foscarnet; Health Care Surveys; Humans; Pharmacy Service, Hospital; Physicians; Societies, Medical; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
[Use of amikacin in a clinic for infectious diseases].
Topics: Amikacin; Communicable Diseases; Humans; Kanamycin | 1979 |